Navigation Links
Bioniche Reports Fiscal 2007 Year-End Results
Date:9/26/2007

tributable to the start of the Phase III pivotal trial with Urocidin in bladder cancer patients whose condition is refractory (unresponsive) to the current standard therapy.

The Company repaid its long-term convertible debt with Laurus Master Funds during Fiscal 2007. US$1,723,307 was repaid on the secured convertible term note through conversion into shares and US$2,845,178 was repaid in cash. A secured revolving line of credit with Laurus Master Funds remains in place, allowing a maximum borrowing limit of US$4.0 million.

The basic net loss per share for Fiscal 2007 was ($0.32) compared to a net loss per share of ($0.03) in Fiscal 2006, which was bolstered by a gain of $0.47 per share from discontinued operations.

"We continue to pursue our strategic objectives with a view to creating shareholder value," added Graeme McRae, President & CEO of Bioniche Life Sciences Inc. "We are focused on obtaining a full Canadian license for our E. coli O157:H7 cattle vaccine, while beginning to sell vaccine to Canadian veterinarians under the Permit to Release Veterinary Biologics. At the same time, we continue to pursue a registration in the U.S. We are also focused on the successful completion of a marketing partnership deal for our bladder cancer technology, while executing our Phase III clinical program with Urocidin and planning for early stage studies to support the use of our MCC technology in the treatment of other human cancers. Meeting these key milestones will, we believe, greatly enhance shareholder value in Bioniche."

Conference Call/Audio Web Cast

Bioniche will host a conference call to discuss Fiscal 2007 results on Friday, September 28, 2007 at 10:00 a.m. Eastern. To participate in the teleconference, call 416-644-3414/toll-free 1-800-733-7571. A listen-only audio web cast will be available at http://www.newswire.ca/en/webcast/viewEvent.cgi?eventI
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014 On July ... Medvedev , presented Russia,s first ... . The Company is developing a unique project called ... BIOCAD develops a number of innovative drugs based on ... The ceremony took place at the International Exhibition "Innoprom ...
(Date:7/10/2014)... Ceres, Inc . (Nasdaq: CERE ), an ... for the three months ended May 31, 2014 and ... reported that the company and its customers have made ... Brazil, which concluded in June, despite dry and hot ... part of the growing season. Yields of several of ...
(Date:7/10/2014)... PNAS (Proceedings of the National Academy of Sciences) ... deprivation have a significant effect on our metabolism. The ... time of day to test for diseases such as ... , Researchers from the University of Surrey and The ... sleep deprivation, body clock disruption and metabolism, and discovered ...
(Date:7/10/2014)... forever. Nanophysics makes sure of that. Mechanics researchers at Linkping ... Physical Review E . Knowledge that can be of ... be able to sit still forever, and walk around upside ... soon be able to buy smart new fasteners that hold ... is, sooner or later the grip is lost, no matter ...
Breaking Biology Technology:Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9Time of day crucial to accurately test for diseases, new research finds 2Even geckos can lose their grip 2
... CALGARY, Oct. 26 /PRNewswire-FirstCall/ - SemBioSys Genetics ... of therapeutic,proteins for metabolic and cardiovascular diseases, ... scientific poster and abstract at the Seventh ... by the Diabetes,Technology Society. The poster will ...
... ECG services, RESEARCH TRIANGLE PARK, N.C., Oct. ... H. Cabell, M.D., MHS,FACC, an expert cardiologist and ... group in Global Clinical Development Services,(CDS). In addition ... for Quintiles ECG Services. Cabell comes to ...
... Pharmasset, Inc.,(Nasdaq: VRUS ) management will be presenting at ... Rodman & Renshaw 9th Annual Healthcare Conference being ... Hotel in New York City. Schaefer ... will provide an overview of the company on Tuesday, ...
Cached Biology Technology:SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting 2Expert Cardiologist Joins Quintiles Medical Group 2Pharmasset to Present at Three Investor Conferences in November 2007 2
(Date:7/10/2014)... 2014 Fingerprint Cards, (FPC,s) ... win (DW). An Asian OEM has selected FPC1021 for a ... in August 2014.   FPC is proud to ... a planned date for start of mass production in August ... SEK 5M, for delivery in the first half of July. ...
(Date:7/10/2014)... An international team ... step of photosynthesis in action for the first time. The ... used the world,s most powerful X-ray flashlight at the US ... molecular complex called photosystem II as it splits water into ... earth,s atmosphere. The researchers report their results in the scientific ...
(Date:7/10/2014)... Marshall Institute for Interdisciplinary Research (MIIR) and the ... today announced they will be partnering with an ... , Under the agreement with Shanghai-based HD Biosciences ... costs and risks of discovery and development of ... any intellectual property and commercialization rights to products ...
Breaking Biology News(10 mins):FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2Scientists watch photosynthesis in action 2Scientists watch photosynthesis in action 3Marshall University to partner with international company in drug development venture 2
... A team of scientists studying the effects of ... its research published in the February issue of the ... said the study,s lead investigator. The study quantified ... the use of electron-beam irradiation. "The purpose of ...
... have led to the discovery of a new species of ... la Muerte". The discovery was made thanks to molecular data ... the overall knowledge of plant lice (one of the most ... 20%. The study was published in the open access journal ...
... DNA sequencing to detect genetic mutations can aid ... Current methods of testing DNA samples, Sanger sequencing ... difficult or impossible to interpret. Scientists at the ... free software program, Pyromaker, that can more accurately identify ...
Cached Biology News:Study shows electron-beam irradiation reduces virus-related health risk in lettuce, spinach 2Study shows electron-beam irradiation reduces virus-related health risk in lettuce, spinach 3A new species of bamboo-feeding plant lice found in Costa Rica 2New virtual tool may provide more accurate diagnosis of genetic mutations 2
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
Rabbit Anti-Mouse Ym1 Polyclonal Antibody,...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
... Analysis of large numbers of samples may be ... which requires minimum operator attention. System ... software and interface CE 4900. The elegant, ... in Windows XP and Windows 98 and 2000., ...
Biology Products: